Full Listing

Below is a full listing of our devices, diagnostics, research tools, therapeutics, and vaccines available for licensing.

SK1303. The h24 Antibody - a Single Agent Drug to Fight Late Stage Melanoma
SK1230. An Effective Cancer Vaccine Combination
SK1197. A Genetic Strategy to Treat Sickle Cell Anemia by Co-regulating Globine Transgene expression and RNAi
SK1186. The Norton Dosing Method
SK1182. Genes that Predict and Mediate Breast Cancer Metastasis to the Lung
SK1181. Cancer Marker Discovery and Validation
SK1178/1179. Promotion of Cell Migration and Axon Regeneration in the CNS
SK1175. Functionalized Nanotube Therapeutic Compositions
SK1164. New Agents to Treat Bacterial Infections and more Specifically Antibiotic-resistant Infections
SK1144. Multiple Splice Variants of MU Opioid Receptors
SK1141. Sensitive Method For Detection of Cancer Cells in body Fluids Usinf Herpes Simpleas Virus
SK1116. Synthesis and Uses of Normal and Transformed Prostate-Specific Antigen Glycopeptides
SK1094. An Effective Cancer Vaccine Combination
SK1092. Assays for Detection of Bioactive Compounds that Interact with Heat Shock Protein-90
SK1089. Method for Early Detection of Ovarian Cancer
SK1087. Ningalin B Analogs Employable for Reversing Multidrug Resistance
SK1084. Tumor-Specific Serum Peptidome Patterns: Detection and Classification of Cancers
SK1077/977/879. Conjugated Antigen-based Cancer Vaccines
SK1071. Migrastatin Analogs as Potent Cell Migration Inhibitors
SK1063/966. An Improved Apparatus for One-Lung Isolation
SK1036/867/766. Adoptive Immunotherapy
SK1023. Synergy Between Mu Opioid Ligands: Evidence for Functional Interactions Among Mu Opioid Receptor Subtypes
SK1020. Immunosuppressive Ningalin Compounds
SK1017. Apparatus for Growing Cells Under Variable Hydrostatic Pressures
SK1013. A Novel Oncogene Implicated in Cancer of the Upper Aerodigestive Tract
SK 996/863/862/605. Opioid Package
SK 944. Treatment of Cancer with ATP Depletion Therapy
SK 937. New Drug Target for Sensitization of Cancer Cells to Radiation and Chemotherapy
SK 934. Analogs of Actinonin as Antitumor Compounds
SK 932. Cryoarray System and Methods for Creating a Frozen Tissue Array
SK 896. Protection of the Female Reproductive System from Natural and Unnatural Insults
SK 894. Treatment of Autoimmune Diseases with 2-Bromopalmitate
SK 872. Tools for the Discovery of New Antifungal Drugs by Targeting Essential mRNA Cap Formation
SK 851. Anti-HuR Monoclonal Antibodies
SK 848. Anti-resorptive Bone Cements and Allogenic, Autographic, and Xenographic Bone Grafts
SK 841. A Novel Device that Enhances Chemotherapy Effectiveness in Solid Tumors
SK 764. A New Diagnostic Marker for Diffuse Large-cell Lymphoma
SK 763. Antitumor Activity of Actinonin
SK 749. Immunity Against Human Cancer Cells Induced by Altered Antigen
SK 737. Acid Sphingomyelinase: A New Drug Target to Regulate Apoptosis
SK 708/727. Protection of Bone Marrow from Toxicity to Chemotherapeutic Agents
SK 707. Use of Inhaled Retinoids in Cancer Prevention
SK 684. Combinations of PKC Inhibitors and Therapeutic Agents for Treatment of Cancer
SK 683. Methods and Reagents for Typing HLA Class I Genes
SK 674. Diagnostic and Therapeutic Applications of Retinol Dehydratase
SK 655. Ardeemins and Ningalins as Multidrug Reversal Agents
SK 641. Method to Predict Chemosensitivity of Tumors
SK 596. Cancer Diagnosis and Prognosis by Determining Levels of MDM2 and p53 and Antibodies Against MDM2
SK 520. Novel Retro-alpha-Retinol Derivatives and Their Uses
SK 501. Methods for Stimulating Growth and/or Proliferation of Stem Cells
DNA Vaccines to Treat Cancer and Infectious Diseases

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2008 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org